IP Library › Granted Patent US 10,858,651
Granted Patent B2
US 10,858,651 · App. 16/553,915 · Granted Dec 8, 2020

Compositions and methods for enrichment of nucleic acids

Inventors: Yu-Chih Tsai (Fremont, CA); Igor Vilfan (East Palo Alto, CA); Khai Luong (San Francisco, CA)
Assignee: Pacific Biosciences of California, Inc.
C12N15/1093C12Q1/6806C12Q1/6869C40B50/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,858,651
App. No.
16/553,915
Granted
Dec 8, 2020
Kind
B2
Abstract

Methods are provided for reducing the complexity of a population of nucleic acids prior to performing an analysis of the nucleic acids, e.g., sequence analysis. The methods result in a subset of the initial population enriched for a target region, which is typically located within one or more target fragments. The methods are particularly useful for analyzing populations having a high degree of complexity, e.g., chromosomal-derived DNA, whole genomic DNA, or mRNA populations.

Claims (26)

1. A method for sequencing a target region in a DNA library comprising:

a) generating a reaction mixture by combining (i) a DNA library comprising double-stranded DNA fragments with exonuclease-resistant adapters on both ends, wherein one or more of the double-stranded DNA fragments are target DNA fragments comprising a target region, and (ii) an engineered endonuclease specific for a first DNA sequence within the one or more target DNA fragments;

b) placing the reaction mixture under conditions that promote cleavage of the first DNA sequence by the engineered endonuclease to produce double-stranded ends;

c) linking sequencing adapters that are resistant to exonuclease digestion to the double-stranded ends in the reaction mixture, wherein the sequencing adapters have a different sequence than the exonuclease-resistant adapters, thereby forming asymmetric-adapter-ligated fragments;

c) treating the reaction mixture with (i) an endonuclease specific for a second DNA sequence within one or more non-target DNA fragments and (ii) one or more exonucleases that degrade DNA fragments that have at least one end that does not have an adapter;

d) placing the reaction mixture under conditions that promote cleavage of the second DNA sequence by the endonuclease and exonuclease activity; and

e) sequencing the asymmetric-adapter-ligated fragments.

2. The method of claim 1 , wherein the first DNA sequence is flanking the target region.

3. The method of claim 1 , wherein the one or more exonucleases comprises ExoIII and ExoVII.

4. The method of claim 1 , wherein the adapters that are resistant to exonuclease digestion are hairpin adapters.

5. The method of claim 1 , wherein the sequencing adapter is a stem-loop adapter.

6. The method of claim 1 , wherein the sequencing adapter is a linear adapter comprising modified nucleotides.

7. The method of claim 1 , wherein the sequencing reaction is a single-molecule sequencing reaction.

8. The method of claim 7 , wherein the single-molecule sequencing reaction is one that generates nucleotide sequence and epigenetic modification data.

9. The method of claim 7 , wherein the sequencing adapter comprises a primer binding site complementary to a sequencing primer and the single-molecule sequencing reaction is a sequencing-by-synthesis reaction.

10. The method of claim 7 , wherein the single-molecule sequencing reaction is a nanopore sequencing reaction.

11. The method of claim 7 , wherein the single-molecule sequencing reaction generates redundant sequence information from single molecules of the asymmetric-adapter-ligated fragments.

12. The method of claim 1 , wherein the target region is a repeat region comprising at least 50 repeats, is a repeat region that is a diagnostic marker, comprises epigenetic modifications, or comprises an imprinted gene.

13. The method of claim 1 , wherein the engineered nuclease is an RNA-directed Cas9 endonuclease, a TAL Effector Nuclease, a zinc-finger nuclease, or a bacteriophage P1 recombination enhancement function protein.

14. The method of claim 1 , wherein the double-stranded DNA fragments in the DNA library are not amplified nucleic acids.

15. The method of claim 1 , wherein the DNA library is a whole-genome DNA library, wherein the whole-genome DNA library is generated by fragmenting genomic DNA and ligating the adapters that are resistant to exonuclease digestion to the ends of the resultant DNA fragments.

16. The method of claim 15 , wherein the fragmenting is done using one or more restriction endonucleases that do not cleave within the target region.

17. The method of claim 1 , wherein the target region is a full-length gene.

18. The method of claim 1 , wherein the first DNA sequence is at least 100 base pairs away from the target region.

19. The method of claim 1 , wherein no end repair is performed prior to the linking step.

20. The method of claim 1 , wherein the DNA library comprises one or more second target DNA fragments comprising a second target region, wherein a second engineered endonuclease specific for a DNA sequence within the one or more second target DNA fragments is combined in the reaction mixture in step (a).

Continuity (4)
Continuation 14995646 · Jan 14, 2016
Continuation In Part 14830293 · Aug 19, 2015
Provisional Application 62039319 · Aug 19, 2014
Related Publication 20200109396A1 · Apr 9, 2020